Proactive “Seekers” Find Solutions at NACDS Regional
Critical trends, information and relationships fueled a highly productive 2020 NACDS Regional Chain Conference, held February 2-4.
Critical trends, information and relationships fueled a highly productive 2020 NACDS Regional Chain Conference, held February 2-4.
Read the complete statement provided to The New York Times in January 2020.
Seven public health priorities urged for Community Preventive Services Task Force
Expansive comments to CMS demonstrate that success of healthcare transformation relies on removing barriers to pharmacy care
The U.S. Supreme Court will review the Eighth Circuit Court’s decision that put the brakes on Arkansas’ PBM law that would ensure that pharmacy reimbursement rates cover pharmacies’ costs of purchasing drugs.
Comments lay out extremely substantive and pivotal case for pharmacy’s value and for pharmacy’s role in the delivery and coordination of care
Pharmacists strong again in latest Gallup “honesty and ethics” survey
Excellence in Patient Care Award recognizes heroes in opioid-abuse prevention and treatment
A coalition of national pharmacy groups today applauded the latest version of the bipartisan Prescription Drug Pricing Reduction Act, released Friday by the Senate Finance Committee, which they say addresses backdoor clawback fees charged by large pharmacy benefit managers (PBMs) that are shuttering pharmacies and costing patients more at the pharmacy counter.
“This legislation represents a potentially major reform that would generate savings and create pricing transparency for pharmacy patients,” said the group. “It would put a stop to the predatory practice of imposing fees on pharmacies long after the point of sale and charging patients more up front for their drugs.”
The coalition represents: The National Community Pharmacists Association (NCPA); National Association of Chain Drug Stores (NACDS); American Society of Consultant Pharmacists (ASCP); National Association of Specialty Pharmacists (NASP); Food Marketing Institute (FMI); National Grocers Association (NGA); American Pharmacists Association (APhA); and the National Alliance of State Pharmacy Associations (NASPA).
The updated draft legislation (S. 2543) released late Friday will require all pharmacy price concessions and DIR fees to be included in the negotiated price at point of sale for Medicare Part D starting Jan. 1, 2022. It would prohibit plans and PBMs from retroactive recoupment. Additionally, the bill would move up the implementation of standardized pharmacy quality measures to 2022.
A previous version of the bill did not address DIR clawbacks, a shortcoming that pharmacy groups warned would be a missed opportunity.
“The current system is unsustainable for patients and pharmacies, and we are grateful to Chairman Grassley and Ranking Member Wyden for listening to our members’ concerns. We look forward to working with the Committee and Senate leaders to pass the legislation.”
Project Lifeline expands as two pioneers receive Excellence in Patient Care Award: Janice L. Pringle, Ph.D., University of Pittsburgh School of Pharmacy Program Evaluation and Research Unit, and Judy Rosser, Blair Drug and Alcohol Partnerships